These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10401943)

  • 1. Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome.
    Jacolot A; Incagnoli P; Edouard AR; Tod M; Petitjean O; Samii K; Mimoz O
    Intensive Care Med; 1999 May; 25(5):486-91. PubMed ID: 10401943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis.
    Joukhadar C; Klein N; Mayer BX; Kreischitz N; Delle-Karth G; Palkovits P; Heinz G; Müller M
    Crit Care Med; 2002 Jul; 30(7):1478-82. PubMed ID: 12130965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing.
    Lipman J; Wallis SC; Rickard CM; Fraenkel D
    Intensive Care Med; 2001 Feb; 27(2):363-70. PubMed ID: 11396280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-amoxiclav pharmacokinetics during posttraumatic hemorrhagic shock.
    Mimoz O; Schaeffer V; Incagnoli P; Louchahi K; Edouard A; Petitjean O; Tod M
    Crit Care Med; 2001 Jul; 29(7):1350-5. PubMed ID: 11445684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
    Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
    Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria.
    Roos JF; Lipman J; Kirkpatrick CMJ
    Intensive Care Med; 2007 May; 33(5):781-788. PubMed ID: 17342515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefpirome in critically ill patients with renal failure treated by continuous veno-venous hemofiltration.
    Van der Werf TS; Fijen JW; Van de Merbel NC; Spanjersberg R; Möller AV; Ligtenberg JJ; Tulleken JE; Zijlstra JG; Stegeman CA
    Intensive Care Med; 1999 Dec; 25(12):1427-31. PubMed ID: 10660852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single- and multiple-dose pharmacokinetics of intravenous cefpirome (HR810) to healthy volunteers.
    Nakayama I; Akieda Y; Yamaji E; Nitta Y; Ohishi M; Katagiri K; Imamura N; Takase K
    J Clin Pharmacol; 1992 Mar; 32(3):256-66. PubMed ID: 1564130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose Optimization of Cefpirome Based on Population Pharmacokinetics and Target Attainment during Extracorporeal Membrane Oxygenation.
    Kang S; Jang JY; Hahn J; Kim D; Lee JY; Min KL; Yang S; Wi J; Chang MJ
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefepime versus cefpirome: the importance of creatinine clearance.
    Lipman J; Wallis SC; Boots RJ
    Anesth Analg; 2003 Oct; 97(4):1149-1154. PubMed ID: 14500173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients.
    Mimoz O; Binter V; Jacolot A; Edouard A; Tod M; Petitjean O; Samii K
    Intensive Care Med; 1998 Oct; 24(10):1047-51. PubMed ID: 9840238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent systemic inflammatory response syndrome is predictive of nosocomial infection in trauma.
    Bochicchio GV; Napolitano LM; Joshi M; Knorr K; Tracy JK; Ilahi O; Scalea TM
    J Trauma; 2002 Aug; 53(2):245-50; discussion 250-1. PubMed ID: 12169929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefpirome clinical pharmacokinetics.
    Strenkoski LC; Nix DE
    Clin Pharmacokinet; 1993 Oct; 25(4):263-73. PubMed ID: 8261711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
    Wallis SC; Mullany DV; Lipman J; Rickard CM; Daley PJ
    Intensive Care Med; 2001 Apr; 27(4):665-72. PubMed ID: 11398692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pus.
    Sauermann R; Feurstein T; Karch R; Kjellsson MC; Jäger W; Böhmdorfer M; Püspök A; Langenberger H; Wild T; Winkler S; Zeitlinger M
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1419-23. PubMed ID: 22441316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefpirome in pediatric patients.
    Nahata MC; Barson WJ; Puri SK
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2348-9. PubMed ID: 8619595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.
    Wiseman LR; Lamb HM
    Drugs; 1997 Jul; 54(1):117-40. PubMed ID: 9211085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranes.
    Thalhammer F; Schmaldienst S; Elmenyawi I; Atteneder M; Burgmann H; Hollenstein U; Georgopoulos A; Graninger W; Putz D; Rosenkranz AR; Mayer G; Hörl WH; Breyer S
    Clin Pharmacol Ther; 1996 Dec; 60(6):645-50. PubMed ID: 8988066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin.
    Kavi J; Andrews JM; Ashby JP; Hillman G; Wise R
    J Antimicrob Chemother; 1988 Dec; 22(6):911-6. PubMed ID: 3243739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and multiple dose pharmacokinetics of intravenous cefpirome (HR 810), a novel cephalosporin derivative.
    Malerczyk V; Maass L; Verho M; Hajdú P; Klesel N; Rangoonwala R
    Infection; 1987; 15(3):211-4. PubMed ID: 3610330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.